Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies

A. R. Tambur*, B. Audry, C. Antoine, C. Suberbielle, D. Glotz, C. Jacquelinet

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

We reported that current assignment of HLA-DQ is a barrier to organ allocation. Here we simulated the impact of incorporating HLA-DQ antigens and antibodies as A/B and αβ allelic variants, respectively, on calculated panel reactive antibody (cPRA) and probability of finding potential compatible donors (PCD). A cohort of 1224 donors and 2075 sensitized candidates was analyzed using HLA-DQαβ allelic (study) versus serologic (current practice) nomenclature. A significant (p < 10−4) decrease in cPRA was observed with higher impact for male versus female, and first transplant versus retransplant (p < 10−4), affecting mostly patients with moderate cPRA (30–80%). Consequently, the number of patients qualifying for 100% cPRA points according to the United Network for Organ Sharing–Kidney Allocation System decreased by 37%. More critically, by using allelic versus serologic nomenclature for HLA-DQ, the number of PCDs for all patients was increased, with male and first-transplant patients showing a higher expansion compared with female and retransplants. Patients of blood group O showed the highest benefit. The goal of reporting unacceptable antigens is to improve accuracy of virtual crossmatching and increase the likelihood of finding immunologically compatible donors. Our simulation provides strong support for the need to re-evaluate the use of allele typing and how HLA-DQ antigens and antibodies are incorporated into allocation policies to ensure equity.

Original languageEnglish (US)
Pages (from-to)3149-3158
Number of pages10
JournalAmerican Journal of Transplantation
Volume17
Issue number12
DOIs
StatePublished - Dec 2017

Keywords

  • clinical research/practice
  • histocompatibility
  • kidney transplantation/nephrology
  • major histocompatibility complex (MHC)
  • organ allocation
  • organ procurement and allocation
  • simulation

ASJC Scopus subject areas

  • Immunology and Allergy
  • Transplantation
  • Pharmacology (medical)

Fingerprint

Dive into the research topics of 'Harnessing Scientific and Technological Advances to Improve Equity in Kidney Allocation Policies'. Together they form a unique fingerprint.

Cite this